Sign In
Samples
/
Takhzyro
Rare Disease
Takhzyro
lanadelumab-flyo
Manufacturer
Takeda
Indication
Plasma kallikrein inhibitor for hereditary angioedema (HAE)
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with Takeda
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from Takeda
View all
Vyvanse
lisdexamfetamine dimesylate
Psychiatry
Entyvio
vedolizumab
Gastroenterology
Trintellix
vortioxetine
Psychiatry
Ninlaro
ixazomib
Oncology
More Rare Disease Samples
View all
Spinraza
nusinersen
Biogen
Skyclarys
omaveloxolone
Biogen
Popular Samples
Browse all
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Eliquis
apixaban
Pfizer
Cardiovascular
Keytruda
pembrolizumab
Merck
Oncology
Dupixent
dupilumab
Sanofi
Immunology
Eylea
aflibercept
Regeneron
Ophthalmology
Xarelto
rivaroxaban
Janssen (J&J)
Cardiovascular
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas
Takhzyro (lanadelumab-flyo) Drug Samples | PrescriberPoint | PrescriberPoint